NEW YORK (GenomeWeb News) – Olink and researchers from Uppsala University in Sweden have formed a new firm, called Olink Genomics, with the goal of commercializing technology for sample-preparation applications in the next-generation sequencing market, Olink said yesterday.
 
The new subsidiary of Olink intends to launch the Selector Technology, which researchers from Olink and Uppsala have developed for sequence-selective sample prep. Olink said that the technology would be rolled out as a service and as reagent kits.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.